Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giacomini

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Poultry Science|March 25, 2017
Effect of broiler breeders fed with corn or sorghum diet and canthaxanthin supplementation on production and reproductive performanceC E V Bonilla, A P Rosa, A Londero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 22, 2024
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple SclerosisJiwon Oh, Virender Bhan, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2022
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractionsIan J Tagge, Ilana R Leppert, Dumitru Fetco, et al.
Frontiers in Neurology|September 25, 2023
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking softwareÉtienne de Villers-Sidani, Patrice Voss, Natacha Bastien, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 15, 2018
Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care PractitionerJiwon Oh, Marie-Sarah Gagné-Brosseau, Melanie Guenette, et al.
Annals of Clinical and Translational Neurology|January 20, 2016
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosisMackenzie A Michell-Robinson, Craig S Moore, Luke M Healy, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Poultry Science|March 25, 2017
Effect of broiler breeders fed with corn or sorghum diet and canthaxanthin supplementation on production and reproductive performanceC E V Bonilla, A P Rosa, A Londero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 14, 2020
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group RecommendationsMark S Freedman, Virginia Devonshire, Pierre Duquette, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 22, 2024
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple SclerosisJiwon Oh, Virender Bhan, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2022
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractionsIan J Tagge, Ilana R Leppert, Dumitru Fetco, et al.
Frontiers in Neurology|September 25, 2023
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking softwareÉtienne de Villers-Sidani, Patrice Voss, Natacha Bastien, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 15, 2018
Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care PractitionerJiwon Oh, Marie-Sarah Gagné-Brosseau, Melanie Guenette, et al.
Annals of Clinical and Translational Neurology|January 20, 2016
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosisMackenzie A Michell-Robinson, Craig S Moore, Luke M Healy, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Pageof 8